Caprock Group, Inc. Edwards Lifesciences Corp Transaction History

Caprock Group, Inc.

$2.71 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$72.54 - $95.56 $2,829 - $3,726	39 Added 0.59%	6,640 $634,000
Q4 2023 Jan 18, 2024	SELL	$61.71 - $77.76 $124,037 - $156,297	-2,010 Reduced 23.34%	6,601 $503,000
Q3 2023 Oct 18, 2023	BUY	$69.28 - $93.38 $27,157 - $36,604	392 Added 4.77%	8,611 $596,000
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $46,566 - $53,956	-572 Reduced 6.51%	8,219 $775,000
Q1 2023 Apr 26, 2023	BUY	$74.26 - $84.51 $652,819 - $742,927	8,791 New	8,791 $727,000
Q3 2022 Nov 07, 2022	BUY	$82.37 - $107.29 $792,481 - $1.03 Million	9,621 New	9,621 $795,000
Q2 2022 Jul 26, 2022	SELL	$86.5 - $128.27 $917,505 - $1.36 Million	-10,607 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$101.96 - $128.34 $1.08 Million - $1.36 Million	10,607 New	10,607 $1.25 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $786,000 - $982,125	-9,375 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$78.68 - $90.67 $11,880 - $13,691	-151 Reduced 1.59%	9,375 $784,000
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $77,783 - $98,984	1,085 Added 12.85%	9,526 $866,000
Q3 2020 Oct 29, 2020	SELL	$67.19 - $87.44 $19,821 - $25,794	-295 Reduced 3.38%	8,441 $674,000
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $380,742 - $509,178	6,617 Added 312.27%	8,736 $604,000
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $2,201 - $3,402	42 Added 2.02%	2,119 $400,000
Q4 2019 Feb 04, 2020	SELL	$71.7 - $82.09 $1,434 - $1,641	-20 Reduced 0.95%	2,077 $485,000
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $2,031 - $2,489	-33 Reduced 1.55%	2,097 $461,000
Q2 2019 Jul 23, 2019	SELL	$55.74 - $64.41 $16,164 - $18,678	-290 Reduced 11.98%	2,130 $393,000
Q1 2019 Apr 12, 2019	BUY	$47.89 - $64.05 $37,785 - $50,535	789 Added 48.38%	2,420 $463,000
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $48,359 - $59,331	-1,042 Reduced 38.98%	1,631 $250,000
Q3 2018 Oct 17, 2018	SELL	$45.7 - $58.03 $35,600 - $45,205	-779 Reduced 22.57%	2,673 $465,000
Q2 2018 Jul 23, 2018	BUY	$42.45 - $51.3 $8,150 - $9,849	192 Added 5.89%	3,452 $503,000
Q4 2017 Jan 17, 2018	BUY	$33.79 - $39.39 $9,292 - $10,832	275 Added 9.21%	3,260 $394,000
Q3 2017 Oct 23, 2017	BUY	$36.29 - $38.83 $108,325 - $115,907	2,985	2,985 $326,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account